SUBSCRIBE
SUBSCRIBE

Brandon May

Bintrafusp Alfa failed again.
Drug Development
GSK, Merck KGaA’s BTC Drug, Bintrafusp Alfa Fails for Second Time This Year
Topline data from Merck KGaA’s Phase II INTR@PID BTC 047 study show bintrafusp alfa has single-agent efficacy and safety in the second-line treatment of locally advanced or metastatic biliary tract cancer in patients who have either failed or are intolerant to first-line platinum-based chemotherapy.
March 16, 2021
 · 
3 min read
 · 
Brandon May
Michael Vi/Getty Images, Mark Wildgust_Janssen Bio
Drug Development
Janssen’s Psoriatic Arthritis Drug, TREMFYA, Proves Long-Term Efficacy in Two-Year Trial
Long-term data from Janssen’s Phase III DISCOVER-2a trial show that TREMFYA® (guselkumab), a selective IL-23 inhibitor, lead to skin clearance and joint symptom relief for up to two years in patients with active psoriatic arthritis.
March 16, 2021
 · 
2 min read
 · 
Brandon May
Aron Knickerbocker Courtesy of Aulos Bioscience
Business
Former Five Prime CEO Aron Knickerbocker Named CEO of Aulos Bioscience
Aron Knickerbocker, former Chief Executive Officer (CEO) of RayzeBio and Five Prime Therapeutics, has taken the helm of Aulos Bioscience, a relatively new biotech company focused on the development of highly differentiated interleukin-2 (IL-2)-binding monoclonal antibodies the treatment of solid tumors.
March 15, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Three Biotechs Obtain Millions in New Financing Rounds Announced Monday
Several biotech companies have announced closings of million-dollar financing rounds Monday, with Cambridge, Mass.-based cell and gene therapy company ElevateBio leading the pack. ElevateBio announced it raised $525 million in a Series C financing round, which the company says should help expand its drug programs as well as manufacturing capacity and current and future partnerships.
March 15, 2021
 · 
4 min read
 · 
Brandon May
Saftey review of Zynteglo is live.
Drug Development
EMA Launches Safety Review After Patient of Zynteglo Gene Therapy Trial Develops Blood Cancer
The European Medicines Agency has launched a safety review of bluebird bio’s thalassaemia drug Zynteglo, a conditionally licensed gene therapy in Europe.
March 12, 2021
 · 
2 min read
 · 
Brandon May
Drug Development
Hospitalized COVID-19 Death Risk Dropped by 92% With NSAA Drug Proxalutamide
Topline results from a trial in Brazil show that treatment with Kintor’s proxalutamide cut mortality risk by 92% and significantly shortened the median length of hospital stay by nine days compared with standard of care in hospitalized patients with COVID-19.
March 11, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Machine Learning Model Predicts Innovation’s Brilacidin Highly Effective Against COVID-19
A machine learning model that screened 1,482 compounds potentially effective for treating coronavirus disease 2019 (COVID-19) has ranked Innovation Pharma’s COVID-19 candidate brilacidin in the top 3% of compounds predicted to be most effective against the novel coronavirus.
March 10, 2021
 · 
3 min read
 · 
Brandon May
Courtesy of Getty Photos
Job Trends
Lilly’s Antibody Combo Reduces Death, Hospitalization in Early COVID-19
Bamlanivimab is a product born from a collaboration between Lilly and AbCellera, with Lilly reportedly developing the therapy in under three months following discovery by AbCellera.
March 10, 2021
 · 
3 min read
 · 
Brandon May
Job Trends
COVID-19 Vaccine Makers Top List of 2021’s Most Innovative Biotechs
In a list of the most innovative vaccine makers in 2021, Fast Company has outlined 10 biotech companies that continue to revolutionize the drug-discovery landscape.
March 9, 2021
 · 
4 min read
 · 
Brandon May
CDC approved vaccines for adults to boost the immu
Business
New CDC Guidance for Fully Vaccinated People Brings Hope (and Criticism)
In the wake of an increasingly accelerated COVID-19 vaccine rollout, the CDC has released new guidance statements that give fully vaccinated individuals more freedom to socialize and participate in pre-pandemic activities.
March 9, 2021
 · 
3 min read
 · 
Brandon May
Vyrologix can help improve hospitalized COVID-19 p
Drug Development
CytoDyn’s Vyrologix Shortens Hospital Stays, Improves Survival in Severe COVID-19
The findings from the late-stage trial of Vyrologix have not been published, but CytoDyn said it is preparing a manuscript of the study data for submission.
March 8, 2021
 · 
2 min read
 · 
Brandon May
Lone Star Bio
Proteomics Approach Finds Aggressive Cancer Drivers and Identifies Treatments
Baylor College of Medicine researchers suggest that the analysis of all protein data from aggressive human cancers could help identify novel treatment targets.
March 5, 2021
 · 
3 min read
 · 
Brandon May
Researchers Make Headway on Universal Flu Vaccine Candidate
A recent study published in Science Translational Medicine shows that a new flu vaccine appears to protect monkeys against influenza strains that are likely to cause a global pandemic.
March 5, 2021
 · 
3 min read
 · 
Brandon May
Courtesy of Getty Images
Drug Development
Phase III Trial Shows Lilly’s Tirzepatide is Superior to Rival in Type 2 Diabetes
Lilly’s tirzepatide has been proposed as a potentially effective treatment option that may rival the efficacy of semaglutide.
March 4, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Study: Convalescent Plasma Doesn’t Prevent Progression of COVID-19 in At-Risk People
Another study is adding to a growing body of literature that suggests convalescent plasma from recovered patients with COVID-19 doesn’t prevent further COVID-19 progression in at-risk people who visit the emergency room.
March 4, 2021
 · 
3 min read
 · 
Brandon May
Load More